Antiviral therapy may prevent liver injury in hepatitis B/TB co-infection

Receiving antiviral treatment for hepatitis B (HBV) at the time of tuberculosis (TB) diagnosis reduced hospitalizations as a result of drug-induced liver injury by 56%, indicating that patients with TB and HBV co-infection should be given antiviral treatment for HBV when anti-TB therapy is initiated, according to a study published in Clinical Infectious Diseases.